معلومات مباشر
معلومات مباشر
جاهز للتشغيل
جاهز للتشغيل
BioWorld, the company behind the Kraken platform, plans to invest $100 million in NASDAQ’s venture capital arm to develop tokenized shares, expand market infrastructure, and enhance trading surveillance technologies. The tokenized shares are expected to be launched in the second quarter of 2027; these are digital representations of securities recorded on a blockchain network, without granting holders direct ownership of the underlying assets. This investment aims to accelerate trading and settlement processes, broaden trading platforms to include multiple financial assets, and support market oversight through NASDAQ’s platforms. It reflects Wall Street’s trend toward integrating tokenized securities into traditional markets. Experts believe this development will improve liquidity and increase the efficiency of capital and asset transfers.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading